Results 201 to 210 of about 58,733 (293)

Evaluating Harm Reduction Advice From Large Language Models

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Large language models (LLM) and generative Artificial Intelligence are increasingly providing health information. We have applied a novel method to evaluate the harm reduction information generated by popular LLMs. We focused on the filtration of oral medications for injection and the availability of local harm reduction services.
Khy Choo, Nathan Smith, Bernadette Ward, Robert M. Lundin   +3 more
wiley   +1 more source

Long-Acting Injectable Buprenorphine in Pregnancy. [PDF]

O G Open
Nacev EC, Prewitt KC, Peng L, Song E, Englander H, Liu P.   +5 more
europepmc   +1 more source

Intravenous Opioid Dose Titration for Refractory Cancer Pain: A Comparative Analysis of Switching from Transdermal Fentanyl to Morphine or Methadone. [PDF]

Pain Ther
Mercadante S, Grassi Y, Lo Cascio A, Sapienza G, Sanzo F, Casuccio A.   +5 more
europepmc   +1 more source

A Comparative Analysis of Deaths Due to Drug‐Related Causes Between Rural and Urban Areas in the United Kingdom, 1997–2026

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Multiple jurisdictions report disproportionately elevated rates of drug‐related harm in urban settings, alongside unique treatment needs in rural populations. We examined differences in case characteristics, circumstances of death and implicated drugs among individuals dying from drug‐related causes, stratified by rural or urban ...
Emmert Roberts, Jürgen Rehm, Caroline Copeland   +2 more
wiley   +1 more source

A study of positive and negative factors associated with tapering off methadone maintenance treatment. [PDF]

Indian J Psychiatry
Kumar K, Shekhawat BS, Yadav S, Gothwal R, Rangrez MA.   +4 more
europepmc   +1 more source

The silent consequence of overdose: The case for brain injury‐informed opioid treatment

Addiction, Volume 121, Issue 11, Page 3142-3144, November 2026.
Nathaniel Day, Kym Kaufmann, Mauricio Garcia‐Barrera, Jitender Sareen, Daniel Vigo   +4 more
wiley   +1 more source

Opioid Modulation of Major Neurotransmitter Systems: Acute, Chronic, and Withdrawal Effects

European Journal of Neuroscience, Volume 64, Issue 9, November 2026.
Opioids are widely used but also frequently misused drugs that affect multiple neurotransmitter systems, including dopaminergic, glutamatergic, GABAergic, serotonergic, and cholinergic pathways. Opioid‐induced neuroadaptations depend on the duration of drug exposure, with distinct changes also emerging following drug discontinuation.
Daniela Novakova, Eliska Pritulova, Jiri Novotny   +2 more
wiley   +1 more source